# PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases

> **NCT02649985** · PHASE1,PHASE2 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 250 (estimated)

## Conditions studied

- Multiple Sclerosis
- Alzheimer's Disease

## Interventions

- **DRUG:** [F-18]PBR06
- **DRUG:** [C-11]PBR28

## Key facts

- **NCT ID:** NCT02649985
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-05-02
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02649985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02649985, "PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02649985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*